FGAM
RGNX icon

Financial Gravity Asset Management’s Regenxbio RGNX Stock Holding History

Financial Gravity Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-945
Closed -$55K – 1584
2019
Q1 		$55K Buy
+945
New +$46.8K 0.04% 292
2018
Q3 		$41K Buy
+674
New +$48.6K 0.04% 375

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Financial Gravity Asset Management's RGNX Position: Q2 2019 in Review

Financial Gravity Asset Management sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 945 shares — an estimated $55K sold.

Financial Gravity Asset Management first reported a position in RGNX in Q3 2018 and held it in 2 quarters. The position peaked at $55K in Q1 2019. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

  • Financial Gravity Asset Management reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
  • Financial Gravity Asset Management sold 945 Regenxbio shares in Q2 2019, an estimated $55K.
  • Financial Gravity Asset Management first reported a position in Regenxbio in Q3 2018 and held it in 2 quarters.
  • Financial Gravity Asset Management's Regenxbio position peaked at $55K in Q1 2019.
  • 186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on Financial Gravity Asset Management's 13F filing for Q2 2019, filed 26 Jul 2019.